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Clinical case: An atypical presentation of a common 
infection
Presentation of  the case
A six-year-old girl presented with a one year history of  
painless, non-purulent conjunctivitis of  her left eye which 
had been treated on two occasions with topical antibiotics 
with no effect; Figure 1. Her vision was unaffected and she 
had no photophobia or blepharospasm. She had a two-week 
history of  fever and anorexia but had previously been fit and 
healthy with no significant past medical history of  note.  She 
was referred to our clinic after re-presenting to The Lions 
Sight Eye Hospital with a persistent, painless red eye.
Examination of  the left eye revealed four discreet, raised, 
conjunctival lesions near the corneal limbus with a small 
adjacent corneal opacity and surrounding inflamed 
conjunctival vessels. (Figure 1). Her right eye was completely 
normal. She was also noted to have submandibular, axillary 
and epitrochlear lymph-node enlargement and a generalised 
papular-pruritic skin rash but nothing else of  note. The rest 
of  her physical examination was normal. Her HIV status was 
unknown and there was no history of  a tuberculosis (TB) 
contact.
Initial investigations included fundoscopy, which was normal, 
a normal full blood count, and a positive HIV test.
She was subsequently started on treatment and on follow-
up in clinic four weeks later her visible eye signs had almost 
completely resolved; Figure 2. However, the corneal lesion 
persisted. Slit-lamp examination revealed a small, dense 
superficial corneal opacity at six o’ clock that was quiescent. 
The entire inferior quarter of  the cornea was more diffusely 
affected, with mild residual thickening and the formation 
of  a superficial demarcating iron line separating it from the 
superior uninvolved areas of  the cornea. Keratic precipitates 
were present and were most marked on the inferior quarter 
of  the corneal endothelium. There was a mild iritis, but no 
posterior synechiae and no iris nodules or other abnormalities.
1. What classical clinical sign did examination of  
her eye reveal?
2. What further investigations would help to identify 
the underlying cause of  her eye signs?
3. What are the most common causes of  this 
condition? 
4. How would you manage this case?
Figure 3: Mantoux site one week after test completed.
Discussion of  the case
1. Examination of  her eye showed phlyctenular 
conjunctivitis (PC) / phlyctenulosis. (From the Greek, 
meaning a blister or pustule) (See figure 1)
2. A Mantoux (tuberculin skin test) test produced a 
massive, indurated lesion measuring 30mm in diameter, 
which subsequently ulcerated; Figure 3. 
A chest x-ray was completely normal. Induced sputum 
samples were collected and sent for microscopy and M. 
tuberculosis culture.
3. The most common cause of  phlyctenular conjunctivitis 
is a delayed hypersensitivity reaction usually as a result of  
tuberculosis (TB) or staphylococcal infection (which is often 
associated with blepharitis). Rarely it may be due to other 
infectious agents such as coccidiomycosis, candidiasis or 
lymphogranuloma venereum.
4. In view of  the positive Mantoux test the patient 
was commenced on four-drug TB treatment according to 
the standard National TB Programme (NTP) schedule 
– Rifampicin (R), Isoniazid (H), Pyrazinamide (Z), and 
Ethambutol (E)1. One percent hydrocortisone cream was also 
applied to her inflamed Mantoux site to reduce the irritation, 
prevent scratching and secondary bacterial infection. 
Dexamethasone eye drops were commenced to reduce local 
inflammation together with topical antibiotic cover to avoid 
exacerbating any co-existent bacterial infection. 
At follow-up one month later the conjunctival nodules and 
inflammation had almost subsided but the corneal lesion 
persisted. Healing usually occurs over a 10–14 day period, 
with residual stromal scar. Ideally, the patient should be 
reviewed within the first week because of  the potential 
for side effects with topical ocular steroid use. In addition 
Suzanne T Anderson1,2 Anne C Kerr 1,2 
William Chagona3  and Simon J Glover2,4 
1 Malawi-Liverpool-Wellcome Trust Clinical Research Programme, 
Blantyre, Malawi 
2  Queen Elizabeth Central Hospital, Blantyre, Malawi
3  Lions Sight Eye Hospital, Queen Elizabeth Central Hospital, Malawi
4 Department of  Anatomy, College of  Medicine, University of  Malawi
Figure 1: Examination of  left 
eye  at presentation
Figure 2: Examination of  left eye 
one month after treatment  com-
menced
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to worsening co-existant infection these include: cataract 
formation and raised intra-ocular pressure, especially when 
used for several weeks or more. When the symptoms have 
significantly improved the corticosteroid eye drops are 
slowly tapered over two weeks. The patient was referred to 
the HIV clinic for a CD4 count, staging and commencement 
on cotrimoxazole prophylaxis. Her CD4 count was 1050 
which, according to current Malawi National HIV guidelines, 
is well above the minimum level of  350 for initiating anti-
retroviral therapy (ART) in a child over 5 years of  age2. 
However, given that PC may be a presenting feature of  TB 
she was categorised as having WHO Stage 4 disease (extra-
pulmonary TB), referred for ART and commenced on AZT, 
3TC and efavirenz according to the Malawi National HIV 
guidelines. Antiretroviral therapy was started within two 
weeks of  commencing her on RHZE2. 
PC may be a presenting feature of  TB especially in areas of  
high TB endemicity such as Malawi. It frequently presents 
in children between 5-10 years of  age and more often in 
girls. Like erythema nodosum, which may also be associated 
with TB, it is generally thought of  as a hypersensitivity 
reaction to mycobacterial antigens. The hypersensitivity 
can also be associated with uveitis, retinitis, and ischaemic 
retinal vasculitis with widespread vascular occlusion and 
neovascularisation of  the retina3. In these patients, the source 
of  the TB causing the immune response might be difficult to 
locate, as was the case in this patient, and treatment for the 
eye may need systemic steroids to reduce the inflammatory 
response in addition to anti-tuberculous therapy. Any patient 
in whom TB is suspected should always be tested for HIV.
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